Thioredoxin: a key factor in cold tumor formation and a promising biomarker for immunotherapy resistance in NSCLC
Abstract Immune checkpoint blockade (ICB) therapy has shown promising clinical efficacy in cancer treatment, but only a subset of patients experience significant therapeutic responses. Tumor cells respond to internal and external stresses, such as hypoxia and nutrient deprivation, by activating the...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2025-05-01
|
| Serier: | Respiratory Research |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s12931-025-03259-w |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|